CPT1A and prostate carcinoma: For example, in melanoma and prostate cancer cells, interferon-γ secreted by CD8+T cells upregulates the expression of CPT1A, thereby promoting resistance to CAR-T cell therapy and contributing to immunotherapy failure [130].